Abstract:Dongmei Wang, 1 Yimei Yang 2 1 Department of Radiology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China; 2 Department of Obstetrics and Gynecology, Affiliated Hospital of Nantong University, Nantong, People's Republic of China Correspondence: Yimei Yang, Affiliated Hospital of Nantong University, &num20 Xisi Road, Nantong, 226001, People's Republic of China, Email Background: Vitamin D status is indicated by serum 25-hydroxyvitamin D [25(OH)D] levels, and the positive effects of high levels of vitamin D on bone mineral density (BMD) have not been ascertained. Therefore, we performed a study to analyze the association between serum 25(OH)D levels and osteoporosis in postmenopausal women. Methods: We conducted a cross-sectional study using data from the National Health and Nutrition Examination Survey (NHANES). Multiple logistic regression was used to explore the relationship between serum 25(OH)D and osteoporosis of total femur, femoral neck and lumbar spine, with stratified analyses for age (< 65 and ≥ 65 years), BMI (< 25, 25 to < 30, ≥ 30 kg/m 2 ) and survey months (winter months and summer months). Results: In total, 2058 participants were enrolled in our study. In the fully adjusted model, compared with serum 25(OH)D levels < 50 nmol/L, the odds ratios (ORs) and 95% confidence intervals (CIs) of serum 25(OH)D 50–< 75 nmol/L and ≥ 75 nmol/L were 0.274 (0.138, 0.544) and 0.374 (0.202, 0.693) in osteoporosis of total femur, 0.537 (0.328, 0.879) and 0.583 (0.331, 1.026) in osteoporosis of femoral neck, and 0.614 (0.357, 1.055) and 0.627 (0.368, 1.067) in osteoporosis of lumbar spine, respectively. The protective effect of high 25(OH)D was observed at all three skeletal sites in those ≥ 65 years of age, whereas it was observed only in the total femur in those < 65 years of age. Conclusion: In conclusion, adequate vitamin D may reduce the risk of osteoporosis in postmenopausal women in the United States, especially in those aged 65 years and older. More attention should be given to serum 25 (OH) D levels to prevent osteoporosis. Keywords: 25-hydroxyvitamin D, osteoporosis, bone mineral density, postmenopausal women, NHANES Osteoporosis is a major public health problem because of the increased risk of fracture. More than 2 million Americans suffered fragility fractures in 2005, and more than 70% of these occur in women. 1,2 Through dual-energy X-ray absorptiometry (DXA), bone mineral density (BMD) is measured to determine if bone loss (osteopenia or osteoporosis) has occurred. 3 Fifty percent of white women have osteopenia or osteoporosis by age 60 years, and age is a crucial risk factor for bone loss. 4 The prevalence of osteoporosis in women (10–17%) is higher than that in men (3–5%) over the age of 50. 5 Vitamin D is important for bone health. 6 Vitamin D status is indicated by serum 25-hydroxyvitamin D [25(OH)D] levels, and less than 30 ng/mL is considered insufficient. 25(OH)D insufficiency is prevalent among elderly women worldwide, with a prevalence of approximately 52% in North American postmenopausal women. 7 Approximately 85.3% of the postmenopausal Moroccan women with osteoporotic vertebral fractures have vitamin D insufficiency. 8 25(OH)D concentrations decrease significantly with age. 4 Calcium and vitamin D supplementation is recommended to strengthen the bones, prevent and treat osteoporosis. 9–11 Previous articles have investigated the relationship between serum 25(OH)D and BMD by race, gender, adult and elderly populations extensively. 5,9,12 Some studies suppose that vitamin D levels significantly influence BMD and high 25(OH)D concentrations have positive associations with BMD. 13,14 To achieve bone health in general population, the Institute of Medicine (IOM) guidelines and the Endocrine Society guidelines recommend 50 and 75 nmol/L respectively as sufficient levels of 25(OH)D. 15,16 In a study of 1829 men and postmenopausal women older than 45 years, the highest BMD at lumbar spine and total hip correspond to higher 25(OH)D concentrations (53 and 75 nmol/L, respectively). 17 Another study suggests that higher vitamin D levels maintain bone health and a greater drop in vitamin D results in a greater reduction in BMD of total hip and femoral neck. 18 However, there is controversy regarding whether higher serum 25(OH)D has positive effects on BMD. The result of a cohort study, however, suggests that postmenopausal bone loss cannot be slowed by high serum 25(OH)D levels in Asian women. 19 -Abstract Truncated-

The Relationship between 25 (OH) D Levels (Vitamin D) and Bone Mineral Density (BMD) in a Saudi Population in a Community-Based Setting

Association Between Vitamin D Level and Z-Score Changes of Bone Density in College-Age Saudi Girls: A Cross-Sectional Study

Prevalence and Associated Factors of Vitamin D Deficiency in High Altitude Region in Saudi Arabia: Three-Year Retrospective Study

Bone Mass in Saudi Women Aged 20–40 Years: the Association with Obesity and Vitamin D Deficiency

Impact of vitamin D deficiency on maternal and birth outcomes in the Saudi population: a cross-sectional study

Association between standardized vitamin 25(OH)D and dyslipidemia: a community-based study in Riyadh, Saudi Arabia

Vitamin D Metabolites and Sex Steroid Indices in Postmenopausal Women with and without Low Bone Mass

The Relationship Between Serum 25-Hydroxyvitamin D Levels and Osteoporosis in Postmenopausal Women

Association between serum 25-hydroxyvitamin D levels and bone mineral density in normal postmenopausal women

Seasonal Variations in 25-Hydroxyvitamin D Levels among Pediatric Patients Attending the Healthcare Centre

General Public Awareness Toward Vitamin D Deficiency in Qassim, Saudi Arabia

Influence of diet on bone health in Saudi Arabian women

Vitamin D Status in Saudi Population: A Minireview

Association of serum vitamin D with bone mineral density of middle-aged and elderly patients in southern China

Vitamin D Deficiency and Risk of Hair Loss: Knowledge and Practice of Adult Female Population in Saudi Arabia, 2020

Serum 25-hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal osteoporosis and normal women

Vitamin D Deficiency in Pediatric Oncology Patients: A Single-Center Experience in Saudi Arabia

Relationship between Serum 25-hydroxyvitamin D and Bone Mineral Density, Fracture Risk, and Bone Metabolism in Adults with Osteoporosis/Fractures

Prevalence of Iatrogenic Vitamin D Toxicity Among the Saudi Population of Vitamin D Users Due to Overcorrection

Investigating the relationship between vitamin-D deficiency and glycemia status and lipid profile in nondiabetics and prediabetics in Saudi population

High prevalence of vitamin D deficiency in Asia: A systematic review and meta-analysis.